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1Executive summary
Health workers are at higher risk of influenza infection than the general population. In addition 
to morbidity among health workers, influenza infection may also lead to increased absenteeism, 
presenteeism1 and disruption of medical services. Moreover, influenza infected health workers 
may contribute to nosocomial transmission of infection to their patients, including those at high 
risk for developing severe influenza disease and complications. Hence, the World Health Orga-
nization (WHO) considers health workers to be a priority target group for seasonal influenza 
vaccination. In addition, influenza vaccination of health workers contributes to influenza pan-
demic preparedness. Finally, studies have shown that health workers who are vaccinated against 
influenza themselves are more likely to recommend vaccination to their patients.
This manual serves as a resource to assist users in establishing a national policy for seasonal 
influenza vaccination of health workers. It provides guidance along with a catalogue of available 
tools to facilitate policy development, planning, implementation, monitoring and evaluation of 
influenza vaccination of health workers. The contents of the manual are meant to supplement the 
document titled “Principles and considerations for adding a vaccine to a national immunization 
program: from decision to implementation and monitoring”, published by WHO in 2014.
The main target audiences for this manual include national policy makers; national health plan-
ners; the national programme managers for immunization and occupational health; and those 
responsible for occupational health, health worker immunization and infection control in health 
facilities. Close collaboration between immunization managers, and occupational health and 
infection control programmes is essential to optimize vaccine uptake, and for a cohesive and 
comprehensive approach to influenza control in health facilities.
This manual summarizes the evidence and rationale, provides guidance on key issues, and lists 
available tools for influenza vaccination of health workers, covering three main components of 
vaccine introduction and management: 
1. Establishing an evidence-based national policy for seasonal influenza vaccination 
of health workers.
2. Planning and management of health worker influenza vaccination.
3. Monitoring and evaluation, including assessing vaccination coverage, monitoring 
for adverse events following immunization, impact assessment and post-introduction 
evaluation.
1 Presenteeism refers to health workers who work while ill, yet have reduced accuracy and effectiveness and pose 
a risk to vulnerable patients in their care.
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Objective
This manual serves as a resource and catalogue of available tools to assist country officials in 
deciding upon, planning, implementing and monitoring health worker influenza vaccination in 
order to achieve optimal vaccination coverage. It is not meant to be a prescriptive document, but 
rather articulates general principles and key considerations to support policy formulation; plan-
ning and management of vaccination; and monitoring and evaluation of influenza vaccination of 
health care workers.
The manual also outlines measures to ensure integration of health worker influenza vaccination 
into existing national occupational health policies and occupational safety and health manage-
ment systems of health facilities. It also addresses the opportunity for health worker influenza 
vaccination to promote an integrated approach for monitoring and optimizing the uptake of all 
interventions included in national occupational health policies. In addition, it refers to the rela-
tionship and contribution of health worker vaccination to pandemic influenza preparedness. 
Seasonal influenza vaccination in health workers differs from other vaccine-preventable diseases 
in that vaccination is required annually. However, elements of this manual may be of relevance 
for health worker vaccination in general, particularly the sections on planning and management 
of vaccination and on monitoring and evaluation.
Audience
The main target audience for the manual include: 
1. National policy-making bodies and health planners. 
2. Programme managers for immunization, infection control and occupational health 
programmes at national and subnational levels and those responsible for occupational 
health and infection control in health facilities.
3. Organizations of health workers and employers.
While the different sections of the document may be of greater relevance to one or the other 
group, it is advisable that the document be read as a whole because of the information on a par-
ticular topic may be found in the different sections of the manual.
The document may also be useful to other audiences with an interest in immunization or occu-
pational health.
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Structure of the document
The manual consists of four sections as outlined in Figure 1. However, for clarity and complete-
ness there is some overlap between some of the sections, with cross-references made to the other 
relevant sections.
Figure 1. Structure of the document
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Key related documents
The following documents are important resource materials that complement the guidance in this 
manual.
1. The WHO policy recommendations on seasonal influenza vaccination, including health 
worker vaccination are published in WHO Position Papers. These position papers are peri-
odically updated. 
Vaccines against influenza: WHO position paper – November 2012
https://www.who.int/wer/2012/wer8747.pdf (Accessed 14 Mai 2019)
Principles and considerations for adding a vaccine to a national immunization program: from 
decision to implementation and monitoring. Geneva, World Health Organization, 2014.
http://www.who.int/immunization/documents/general/ISBN_978_92_4_15068_92 
(Accessed 14 Mai 2019)
2. The following document provides detailed guidance to countries that already provide sea-
sonal influenza vaccination to health workers on how to identify, analyse, and effectively 
target issues related to uptake:  
Tailoring immunization programmes for seasonal influenza (TIP FLU). A guide for increasing 
health care workers’ uptake of seasonal influenza vaccination (2015). Copenhagen, World Health 
Organization Regional Office for Europe, 2015.
http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/
publications/2015/tailoring-immunization-programmes-for-seasonal-influenza-tip-flu.-a-guide-
for-increasing-health-care-workers-uptake-of-seasonal-influenza-vaccination-2015  
(Accessed 14 Mai 2019)
3. While the contents of this manual can help inform national policies, the manual does not 
provide an exhaustive review of the available evidence to inform decision-making. A more 
detailed review of such evidence in support of vaccination of health workers is found in the 
following document: 
Rapid Evidence Appraisal: Healthcare Worker Influenza Vaccination – A global review of the 
evidence. January 2017. 
https://www.sciencedirect.com/science/article/pii/S2590136219300373?via%3Dihub 
(Accessed 12 July2019)
4. This manual is part of a series of introduction manuals on seasonal influenza vaccination 
developed by WHO. A manual on the implementation of influenza vaccination of pregnant 
women has been published earlier. 
How to implement influenza vaccination of pregnant women: an introduction manual for national 
immunization programme managers and policy makers.
http://apps.who.int/iris/bitstream/handle/10665/250084/WHO-IVB-16.06-eng.pdf 
(Accessed 14 Mai 2019)
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Health workers are at risk of influenza virus infection and of transmitting infection to patients 
under their care who may be at high risk for severe disease, complications, and death (1). The 
increased risk in health workers compared to the general population may vary by occupation 
or setting (2). WHO considers health workers to be an important priority group for influenza 
vaccination, not only to protect themselves and maintain essential health-care services during 
influenza epidemics, but also to reduce the spread of influenza to vulnerable patient groups with 
whom they come into contact (1). Furthermore, many studies have found that a strong recom-
mendation from health workers, especially from physicians, is highly likely to increase public 
uptake of vaccination (3–5). Health workers who have themselves been vaccinated are more likely 
to be knowledgeable about vaccination and be more effective in improving public acceptance of 
vaccination (3–5). Finally, because health workers are likely to be targets of vaccination programs 
during an influenza pandemic, establishing functional programs for seasonal influenza vaccina-
tion of health workers will facilitate timely and effective vaccination during a pandemic (6).
Current status of influenza vaccination in health workers
Global adoption of a policy for influenza vaccination of health workers has been slow. In 2017, 
only 119 of the 194 countries reporting having a national influenza vaccination policy. Of these, 
96 report targeting health care workers as a priority group. However, the proportion of Member 
States that reported having a policy varies by WHO region, with the majority of countries in the 
WHO regions of the Americas, Europe and Eastern Mediterranean reporting a national policy 
for influenza vaccination, whereas a lower proportion of countries report having such a policy in 
the Western Pacific, African and South-East Asian regions.
Information on influenza vaccination coverage in health workers is not available for most coun-
tries, though it varies widely and is reported to be low in many countries where such data are 
available. For example, data on coverage in health workers were available from only 26 (56%) coun-
tries in the European region for the 2014–15 season. The median coverage was 29.5% with a range 
of 2.6% to 99.5%; only three countries, namely Albania, Armenia and Belarus, reported cover-
age > 75% (7). More recent data from a systematic review through compulsory reporting from all 
hospitals in England showed an uptake of 69% in the 2017–18 season.2 An internet survey of 2000 
health workers in the United States demonstrated coverage to be 78% during the 2017–18 season, 
with higher coverage rates (95%) among those working in settings where they were required by 
their employers to be vaccinated (8). Higher vaccination coverage rates are reported when manda-
tory vaccination policies are implemented. In one systematic review that included eight studies, 
coverage rates exceeding 94% were achieved in all (9). 
2 Seasonal influenza vaccine uptake in healthcare workers (HCWs) in England: winter season 2017 to 2018.  
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/710531/Sea-
sonal_influenza_vaccine_uptake_HCWs_winter_season_2017_to_2018.pdf (Accessed 14 Mai 2019)
6Background and rationale
Summary of a rapid evidence appraisal on the rationale 
for influenza vaccination of health workers
A rapid evidence appraisal of materials available in the English language, published since 2006, 
and considered to be of medium or high quality, was conducted by WHO (10). The questions 
considered, and the main findings of this appraisal are summarized here. Readers are referred to 
the published report for the details and for the relevant citations.
The review considered three issues, namely:
1. The evidence that health workers are at increased risk of influenza infection compared 
to the general population, and that vaccinating them reduces influenza or absenteeism 
and/or the wider economic impact of influenza in the health workforce.
2. The evidence that health workers transmit influenza to their patients in health care set-
tings and, if so, whether vaccination protects the patients and the proportion of health 
workers who need to be protected to obtain this effect.
3. The evidence for successful practical interventions to increase vaccination uptake and 
the state of knowledge of social, behavioural and public health public policy research on 
vaccination uptake in health workers. 
Evidence for health worker risk of influenza and impact of vaccination
Studies comparing the risk of influenza infection in health workers compared to the general 
population are challenging, may measure different outcomes, or are executed in different set-
tings, limiting the comparability across studies or the pooling of data from these studies. Recent 
systematic reviews suggest that health workers are at an increased risk of influenza infection 
compared to the general population (Odds Ratio = 2.08, 95% CI = 1.73 to 2.51) (2), though the evi-
dence is strongest for asymptomatic laboratory-confirmed infection (11). However, health workers 
with asymptomatic infection may still transmit influenza virus to highly vulnerable patients in 
a health-care setting.
Respiratory illness is reported as a common cause of absenteeism among health workers. Epi-
demics or pandemics of inf luenza have been associated with increased rates of absenteeism 
among health workers (12). Vaccine efficacy in health workers has been shown to be as high at 
90% for well-matched seasonal influenza vaccines (13, 14), which suggests that vaccination of 
health workers will reduce influenza-related morbidity and absenteeism. A systematic review 
showed a protective effect against laboratory confirmed influenza and shorter absenteeism due 
to influenza-like illness (ILI) in vaccinated groups (15). A recent study among health workers in 
the United Kingdom showed that a 10% increase in vaccination uptake is associated with a 10% 
decrease in absence due to illness (12). However, there are observational studies that provide con-
flicting results – though often constrained by poor study design, non-specific outcomes, high risk 
of bias, and failure to adjust for confounding factors (16–19).
Since the risk of illness following infection is based on the level of exposure, and absence behaviours 
may vary between different categories of health workers, it is possible that the lack of sufficiently 
granular data on absenteeism, e.g. stratified by health worker categories, may account for the 
mixed results seen in the different studies. On the other hand, the lack of impact on absenteeism 
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observed in some studies, despite evidence of increased rates of infection in health workers, raises 
the question as to whether health workers nonetheless continue to work when infected and lead to 
heightened concerns about the consequent risk of nosocomial transmission (20). Several studies 
have documented presenteeism in health workers with influenza-like illness (21–23), including 
one instance which was associated with nosocomial transmission in an oncology unit (24).
Evidence of transmission of infection from health workers to patients and 
the impact of vaccination
Epidemiological studies using molecular subtyping approaches demonstrate evidence of trans-
mission from health workers to patients. The use of automated collection of high-resolution 
contact data using wearable sensors combined with virologic data have allowed the identification 
of potential routes of transmission in cases of hospital-acquired influenza (25). The extent of direct 
transmission from health worker to patient in health care settings is difficult to capture because 
of the constant influx of visitors, interactions between patients, and the possibility of multiple 
simultaneous introductions of influenza (26–28). However, among those who may contribute to 
transmission of infection in the health care setting, health workers represent a sizeable vaccine-
preventable portion since they are easier to target for vaccination.
The direct patient benefit of health worker vaccination can be measured in several ways, as illus-
trated in the literature. Several studies evaluate the impact on laboratory confirmed influenza, 
while others evaluate impact on non-specific outcomes such as ILI, respiratory illness, all-cause 
mortality, respiratory illness associated mortality, or incidence of nosocomial influenza infec-
tion. The evidence is stronger for non-specific outcomes such as ILI, all-cause mortality (29), 
and incidence of nosocomial influenza infection (30, 31). Although some studies have attempted 
to measure the number of health workers that need to be vaccinated for optimal protection, the 
evidence in support of a coverage threshold is weak, leading to disputes in the literature (32). 
However, it is likely that patient protection is positively associated with increasing health worker 
vaccination coverage but would also depend on other factors including the type of patient contact, 
vulnerability of the patient, use of other infection control measures, and the effectiveness of vac-
cination in a particular influenza season (33–35).
Evidence for interventions to increase health worker vaccination uptake
There is a substantial body of evidence on successful interventions to increase health worker 
influenza vaccination uptake, much of which has been incorporated into existing toolkits aimed 
at increasing vaccine uptake.
Although the factors that contribute to the health worker decision-making pathway are diverse, 
some strategies appear to be more effective than others. No single intervention has been shown to 
rapidly and substantially increase and sustain vaccination uptake except for mandatory vaccina-
tion. However, mandatory health worker vaccination is an issue that has been extensively debated 
with many different perspectives for and against its use (20, 32, 36). Successful mandatory vac-
cination programmes require organizational and educational efforts to secure employee support 
prior to implementation (37).
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A combination of one or more “soft mandates” such as active declination, required surgical mask 
use and exclusion of non-vaccinated staff from working with highly vulnerable patients may be 
used as alternatives to mandatory vaccination, although there are organizational, educational, 
monitoring and enforcement, and human and financial resource implications for applying such 
soft mandates. 
Additional components that contribute to increased uptake include the following:
• Provision of free vaccine;
• Convenient access to vaccination, including on-site vaccination in health facilities;
• Knowledge and behaviour modification through education, reminders, and incentives 
tailored towards different health worker categories;
• Management and organizational approaches such as personnel assigned to oversee vac-
cination activities.
The reasons for low vaccination uptake are heterogenous and vary across different health worker 
categories and cultures. Therefore, approaches to increase uptake need to be tailored for different 
groups. Some studies have demonstrated that formative research, including surveys and qualita-
tive research, can provide insights that assist in tailoring interventions to optimize uptake.
Conclusion
Despite the ongoing debate in the literature, influenza vaccination is important for 
ensuring the safety of health workers, their patients, and the general population who 
rely on a functioning health system, especially during epidemic/pandemic periods. 
Studies to conclusively establish the value of health worker vaccination will be chal-
lenging though the emerging data on this issue will be closely monitored to inform 
any changes to existing WHO policies.3
Global Action Plan for Influenza Vaccines
In an influenza pandemic, most of the world’s population will be highly susceptible to infection 
and it is likely that infection will spread rapidly. Vaccination is considered one of the key strategies 
to mitigate the potential impact of a pandemic. While it is expected that there will be a delay in 
the development of strain-specific pandemic vaccines, insufficient production capacity will further 
restrict the global access to the vaccines, at least in the early phases of the pandemic. Resource-con-
strained countries, especially those that lack local vaccine production capacity and those that do 
not have seasonal influenza vaccination policies, will face the greatest challenge in securing timely 
access to vaccines during a pandemic, and mitigating the substantial adverse effects of a pandemic.
To address this challenge a Global Action Plan for Pandemic Influenza vaccines was developed 
by WHO with short, medium and long term-strategies aimed at increasing influenza vaccine 
3 A working group of the WHO Strategic Advisory Group of Experts (SAGE) on immunization will be reviewing 
the emerging data and updates to the existing WHO recommendations are expected in 2020.
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production and surge capacity before and during an influenza pandemic (38). The plan proposed 
three approaches to enhance access to pandemic vaccines: (i) an increase in the baseline use of 
seasonal influenza vaccination; (ii) an increase in global production capacity; and (iii) further 
research and development.
The first of the above three approaches relies on countries establishing clear and effective immu-
nization policies to increase the baseline use of seasonal influenza vaccines – providing industry 
with better demand forecasts and stimulate increased production capacity. 
While vaccination of health workers will only result in a modest increase in overall vaccine demand, 
it will establish a robust and functional platform for rapidly immunizing health workers and could 
contribute to achieving high coverage in the event of a pandemic, thereby protecting health service 
delivery during a pandemic. Furthermore, high uptake of vaccination by health workers is likely 
to build trust and increase the uptake of vaccination among other high-risk groups targeted for 
seasonal influenza vaccination in national policies. Health worker vaccination may also establish 
or strengthen processes that would allow rapid deployment of pandemic vaccines. Thus, seasonal 
influenza vaccination of health workers goes beyond the issue of immediate protection against 
seasonal influenza as outlined above and contributes to pandemic influenza preparedness.
10
1. Establishing a policy to vaccinate health 
workers against seasonal influenza
The decision to establish a policy to vaccinate health workers against seasonal influenza should 
be evidence-based, with a clear rationale, and with the required investments for sustainable 
implementation. The general principles and considerations for adding a vaccine to a national 
immunization programme are articulated in the 2014 WHO guidance document titled “Principles 
and Considerations for Adding a Vaccine to a National Immunization Programme: From Decision 
to Implementation and Monitoring” (39). 
Health workers comprise a target population not usually included in the national immunization 
programmes of many low and middle-income countries. While hepatitis B vaccination pro-
grammes for health workers may exist, influenza vaccines are unique since vaccination for the 
foreseeable future must be repeated annually. This section of the manual deals primarily with 
additional considerations specific to annual seasonal influenza vaccination of health workers, 
building on the generic framework provided by the document cited above.
The decision-making process
As with any other vaccine for which policies have to be established, Ministries of Health (MoH) 
would request National Immunization Technical Advisory Groups (NITAGs) or equivalent 
national or regional bodies to conduct a review of the evidence and provide advice on establish-
ing a policy for seasonal influenza vaccination of health workers, and to make recommendations 
on the content of the vaccination policy.
Engagement of the many stakeholders affected by this policy is essential to secure their endorse-
ment and facilitate high vaccination uptake, and is likely to result in a more coordinated approach 
to the control of influenza in health facilities. Stakeholder consultation should be broadly sought 
and include: 
1. Professional associations and societies representing different health worker groups such 
as medical, nursing and allied health service associations, as well as representatives of 
private health care providers; 
2. Medical and nursing councils and other health worker regulatory bodies; 
3. Patient safety groups, where they exist, and organizations representing patients, since 
health worker immunization should also be regarded as a patient safety and quality of 
care issue;
4. Health worker unions, where they exist and when their participation is likely to be use-
ful in promoting vaccination uptake.
5. Health facility managers.
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The process should also include early engagement with the bodies that establish occupational 
health policies and regulations to ensure that the policies established for health worker vaccina-
tion against influenza are also reflected in the national occupational safety and health policies. 
If vaccination policies for health workers exist for other vaccines, e.g. hepatitis B vaccination, 
a review of these policies may provide useful inputs for policy formulation for seasonal influenza 
vaccination and on strategies to optimize vaccination uptake.
Where available, NITAGs could access the information required from data available from the 
national influenza surveillance, the National Influenza Centres or other institutions participating 
in the Global Influenza Surveillance and Response System (GISRS) (see Toolbox 1).
In places where local evidence is not readily available, especially on rates of disease amongst health 
workers and on transmission of disease from health workers to patients, efforts to generate such 
evidence could be time- and resource-intensive. Policy-makers would have to consider whether 
it is necessary to conduct local studies or whether data from other countries with similar epide-
miological profiles and health system characteristics could be used to infer the likely burden of 
disease and support decision-making. NITAGs would need to balance the desire to have national 
data against the costs and delays that would result in generating the data and the consequent 
health impacts of this delay.
Toolbox 1. National Influenza Centers 
To monitor and respond to the changes in the influenza virus antigenic structure and the subsequent 
necessity to change vaccine compositions, many countries have established national influenza centers 
(NIC) to collect and characterize virus specimens in their country and perform other analyses to inform 
the decisions of WHO and partners on the composition of the next year’s influenza vaccine. In many 
countries, virologic surveillance is complemented by more systematic influenza surveillance for severe 
acute respiratory illness (SARI) and influenza-like illness (ILI).
A NIC in a country – or in a neighbouring country – can support evidence-based recommendations by 
providing data on the influenza disease burden and seasonality to the NITAG or other relevant national 
decision-making body. Involving these and other centers in NITAG discussions is key to bringing 
together all relevant information that is needed for the decision-making process.
A list of NICS, WHO collaborating centers and essential regulatory laboratories (ERLS) can be found at 
the following links:
 ➠ http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/list 
(Accessed 14 Mai 2019)
 ➠ http://www.who.int/influenza/gisrs_laboratory/collaborating_centres/list 
(Accessed 14 Mai 2019)
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Considerations for decision-making
In addition to the general considerations outlined in the WHO document “Principles and 
Considerations for Adding a Vaccine to a National Immunization Programme: from decision to 
implementation and monitoring” referred to earlier, other key issues need to be considered when 
framing a policy for health worker vaccination. These are listed in Figure 2.
Figure 2. Key considerations in establishing a vaccination policy for health workers
Defining the public health objectives for seasonal influenza vaccination of health workers
Characterizing and prioritizing the target groups for vaccination
Framing the vaccination policy for seasonal influenza vaccination of health workers
Choice of vaccine product, schedule and timing of vaccination
Defining the monitoring and impact assessment objectives
Defining the public health objectives for vaccination
A critical first step in establishing a policy for vaccinating health workers with seasonal influenza 
vaccination would be to clearly define the aims and objectives of the vaccination programme. 
Such objectives may vary between countries but would underlie the prioritization of the health 
worker groups to be targeted for vaccination, set vaccination coverage targets, and provide guid-
ance on the outcomes and scope for measuring the impact of vaccination.
Vaccination of health workers serves multiple objectives. These may include:
1. Prevention of infection in the health workers themselves, averting associated morbidity. 
2. Prevention of transmission of infection from health workers to vulnerable patients, 
including those at high risk of severe disease, complications, and death. 
3. Sustaining health services by reducing health worker absenteeism, especially during seaso- 
nal and pandemic influenza outbreaks, which is a period of increased health care demand.
4. Promoting uptake of seasonal influenza vaccination among other target groups and 
enhance public trust for influenza vaccination.
5. Contributing to influenza pandemic preparedness by:
 – Establishing a mechanism for rapidly immunizing health workers during a pandemic 
of influenza or epidemics of other vaccine-preventable diseases;
13
1. Establishing a policy to vaccinate health workers against seasonal influenza
 – Contributing to increasing demand for influenza vaccine and thereby enhance pro-
duction capacity to improve timely access to vaccine in case of a pandemic.
 – Establishing or strengthening national capacity for vaccine regulation.
One or more of the above could serve in defining the national objectives for health worker vac-
cination. Important considerations when defining vaccination objectives include:
1. Review of the available data on the burden of disease among health workers and health 
care-related infections in patients and residents of long-term care facilities. National 
data, where available, complemented with representative regional or global data or esti-
mates developed through the use of mathematical models may be used for this purpose.
2. The cost and impact of vaccination and availability of vaccine supply.
3. Review of the national pandemic preparedness plan and consideration of how health 
worker vaccination could contribute to pandemic preparedness.
Economic analysis for establishing national policies
While economic analysis is generally recommended prior to deciding on vaccination policies, lack 
of data for estimating and comparing the economic benefits of the different vaccination objectives 
may be a limiting factor, as will be the relatively small size of the target group. Toolbox 2 lists the 
available tools for conducting economic analysis for influenza vaccination.
The costs and economic benefits of influenza vaccination of health workers are likely to depend on 
several factors, including the number and categories of health workers targeted, the incidence and 
severity of infection in the targeted health workers, their contribution to health care-associated 
transmission and the consequences of such infections. These factors may vary between different 
health facilities and will vary from one influenza season to another. 
Toolbox 2. Tools for the economic analysis of seasonal  
influenza vaccination 
Several tools are available for conducting economic analysis of influenza vaccination: 
WHO Guide for Stanardization of economic evaluations of immunization programmes (WHO/IVB/08.14) 
 ƥ http://apps.who.int/iris/bitstream/handle/10665/69981/WHO_IVB_08.14_eng.pdf
WHO Manual for Estimating the Economic Burden of Seasonal Influenza (WHO/IVB/16.04) 
 ƥ http://apps.who.int/iris/bitstream/handle/10665/250085/WHO-IVB-16.04-eng.pdf 
Guidance on the economic evaluation of influenza vaccination (WHO/IVB/16.05) 
 ƥ http://apps.who.int/iris/bitstream/handle/10665/250086/WHO-IVB-16.05-eng.pdf
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A recent systematic review of the epidemiological and economic effects of seasonal influenza 
vaccination of health workers found that vaccination of health workers was cost-saving, based on 
crude estimates of absenteeism averted through vaccination (15). However, all the studies included 
in this review were from high-income countries and took an employer perspective with a strong 
focus on absenteeism averted. 
Initial decisions could take vaccination costs and the impact of these costs to the immunization 
and health budgets into consideration, with the option of measuring cost-effectiveness post-intro-
duction, if required.
Further guidance on costing and budgeting of health worker influenza vaccination, with links to 
the available costing tools and resource materials on immunization financing are covered in the 
next section of this manual.
Characterizing the target groups for vaccination
Ideally all health workers should be targeted for vaccination, including those who may not come 
into direct contact with patients. Even if not in direct contact, health workers could potentially 
transmit infection acquired in the community to colleagues and, thereby, participate in the 
chain of health care-associated transmission of infection. However, in situations where there are 
resource constraints or limited or unstable vaccine supplies, categorization and prioritization of 
health workers for vaccination would be required. Prioritization of health workers would depend 
on assessment of risk of infection among the health workers themselves, transmission of infection 
to their patients and the consequences of health care-associated transmission.
Even without financial resource constraints or limitations in vaccine supply, categorization of 
health workers would be useful when different policies are applied to different health worker cat-
egories, based on risk assessment. For example, a mandatory vaccination policy may be applied 
to select categories of health workers who work with patients at high risk of severe influenza and 
who are more likely to accept mandatory vaccination, while vaccination may be voluntary for 
other categories (40, 41).
Table 1 provides an example of risk categorization of health workers based on risk to themselves 
and of those for whom they care.
The very high-risk category is also the one where the evidence for risk and impact of vaccination 
is the strongest and where there is a stronger justification for vaccination (10).
Those targeted for vaccination should also include part-time personnel, students, contractors, 
and volunteers at the health facility who have possible exposure to patients as health workers in 
the above categories.
Risk categorization of individual health workers may be too complex and resource intensive 
in many settings, especially in low- and middle-income countries. In these situations, simpler 
approaches wherein health worker categories are classified into only two groups, i.e. at high risk 
group (targeted for vaccination) and low risk groups (not targeted for vaccination) may be used.
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Table 1. Risk categorization of health workers
Risk category Health worker characteristics
Very High
• High risk health workers (see below) who work in clinical areas that admit patients at high 
risk for severe disease, complications, or death following influenza virus infection. These 
include intensive care units; transplant or oncology wards; antenatal, peri-natal or post-
natal areas; and areas with elderly individuals, especially those with chronic diseases.
High
• Health workers who come into direct physical contact with patients, or with infectious 
materials, including surfaces or equipment contaminated by infectious materials.
• Health workers who have contact which is not physical but that would allow the acquisi-
tion or transmission of diseases that are spread at short range (1 – 2 m) by respiratory 
means, e.g., counsellors who have prolonged fact-to-face contact (42, 43).
Low
• Health workers who do not have contact with patients and whose normal work is not in 
a clinical area as defined above.
To ensure targeted use of influenza vaccination of health workers and to address potential uptake 
issues, national policies for health worker vaccination should outline:
1. The classification of different health worker categories based on assessment of risk.
2. The policy for vaccination for each category, e.g. whether vaccination is recommended 
and whether the recommendation is for mandatory or voluntary vaccination.
3. Strategies for managing non-compliant health workers and vaccine refusers.
The following document provides an example of a framework for the assessment, classification 
and prioritization of health workers:
The policy directive of the New South Wales Ministry of Health on the Occupational Assessment,  
Screening and Vaccination Against Specified Infectious Diseases
https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/PD2018_009.pdf (Accessed 14 Mai 2019)
Framing an immunization policy for health workers
Recommendations for health worker vaccination could propose either mandatory vaccination, 
voluntary vaccination or a mixed approach depending on the risks in the specific clinical setting.
Multiple studies across many countries has demonstrated that voluntary vaccination of health 
workers, even when accompanied by considerable efforts to educate them on the benefits and risks 
of vaccination and implementation of measures for convenient access to vaccination, results in 
low coverage that seldomly exceeds 70%. On the other hand, mandatory vaccination has resulted 
in close to 100% uptake in institutions in the United States where it has been applied (44–46). 
However, mandatory vaccination has been difficult to implement in some countries because of 
acceptability issues and because the attributable benefits of health worker vaccination have been 
a subject of debate (32). Furthermore, it may not be feasible to implement mandatory vaccination 
policies in resource-constrained settings.
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Voluntary vaccination
One option for a vaccination policy for health workers is voluntary vaccination wherein vaccina-
tion is recommended for health workers and offered but acceptance is voluntary or optional, i.e. 
not a requirement. Such programmes often have low vaccination coverage. Hence, with voluntary 
vaccination, extra efforts are required to optimize the uptake of vaccination. These could include:
1. A robust communications strategy, specifically tailored to the needs of different health 
worker categories, to explain the benefits and risks of vaccination, including the benefits 
to patients, especially those at high risk for severe disease. It needs to be emphasized 
that some of these patients, including the elderly and immunocompromised patients 
may not themselves respond to vaccination and that vaccination of health workers who 
come into contact with them is an important means for protecting them from infection, 
i.e. a professional ethics and moral argument
2. Convenient access to vaccination that is free of charge, and available to workers in every 
shift. Those who work during evening or night shifts might be provided access to vacci-
nation either at the beginning or the end or their shifts or on designated days and times 
to cover their shift.
3. Other demand generation activities as outlined in the next section of this manual.
A number of soft mandates may also help in increasing vaccination uptake, including:
1. Requirement of active declination of vaccination through signing of forms indicating 
their non-participation with or without stating the reasons for not accepting vaccination 
(see Annex 1 for a sample of an active declination form).
2. Reassignment of health workers who refuse vaccination to areas where they are less 
likely to come into contact with high risk patients, if this is feasible, or a requirement to 
wear masks when they do care for patients at high risk of influenza complications.
3. Use of face masks while in the health care facility.
Mandatory vaccination
Mandatory vaccination makes vaccination of health workers a legal or regulatory requirement 
while allowing some exemptions, e.g. medical contraindications. There is no WHO or other 
uniformly applied definition for mandatory vaccination. Infant and childhood immunization 
programmes described as mandatory can vary widely, especially in terms of the exemptions 
allowed and the penalties for non-compliance (47).
Several experts have argued that mandatory immunization policies should be implemented 
against vaccine-preventable diseases that can be transmitted in the health-care setting and cause 
significant risk of morbidity or mortality to patients (20, 44, 48–50), as part of the professional 
ethics of a health care provider.
It has also been argued that few ethical mandates in the practice of medicine surpass the obliga-
tion to do no harm. Hence, ensuring conditions for safe patient care by minimizing transmission 
of communicable diseases represents a minimum ethical standard in health care practice set-
tings (20). However, if mandatory vaccination policies are to be established, legal liability issues 
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will need to be addressed and consideration given to providing compensation in the rare event of 
an adverse event.
Mandatory vaccination could either be part of the national policy or implemented at individual 
health facilities as part of institutional policies. The enactment of legislation endorsing mandatory 
vaccination would facilitate the implementation of such a policy. 
The Code of Colorado Regulations provides an example of a mandatory vaccination policy:
Code of Colorado Regulations - Standards for Hospitals and Health Facilities 02 – General Licensure 
Standards (Part 10, Page 46)
https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=6020&fileName=6%20CCR%20
1011-1%20Chap%2002 (Accessed 14 Mai 2019)
Several countries with voluntary health worker vaccination policies for influenza do have man-
datory vaccination of health workers for other infections such as measles and hepatitis B. These 
existing mandatory vaccination policies could be leveraged to also justify and establish mandatory 
vaccination policies for influenza, based on the protection afforded to the health worker as well as 
to vulnerable high-risk patients with whom they come into contact.
Published recommendations for the ethical implementation of mandatory vaccination policies are 
reproduced in Toolbox 3. These recommendations may be taken into consideration in framing 
the national policy based on the feasibility of implementation.
Toolbox 3. Recommendations for ethically implementing mandatory 
vaccination policies 
There must be a compelling employee and patient safety problem that is clearly communicated to 
employees.
  The least restrictive means should be used to achieve the safety objective.
  There should be clear opt-out criteria for medical reasons.
  Opt-out criteria based on personal views of the health worker should be allowed for current 
employees only. These determinations must be made in a transparent and objective manner.
  For those who do meet medical or other exclusion criteria, or who refuse vaccination, institu-
tions should offer alternative means for achieving transmission control, including temporary 
leave during peak times, mandatory mask wearing, re-assignment to non-clinical areas (if 
feasible) or frequent testing during peak influenza seasons.
  Prospective employees should be notified of the mandatory policy and recognize that failure to 
comply could be grounds for termination of employment.
  The process should be transparent, with a broad range of health worker perspectives involved in 
policy development.
  Institutions should support healthcare workers by implementing vaccination procedures that are 
free, easy to access, and include complete comprehensive coverage of adverse events. Particu-
lar attention should be paid to not burdening less advantaged members of the healthcare team.
Source : Tilburt JC et al. Vaccine 26S (2008) D27-D30 (1)
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Mixed approach
A mixed approach could also be adopted where a mandatory vaccination policy is applied to only 
certain categories of health workers likely to have direct physical contact with high-risk patients, 
while a voluntary vaccination policy is applied to the remaining categories.
Such a policy should clearly and unambiguously define the health worker groups to whom or 
work areas where mandatory and voluntary vaccination policies apply. Consideration should be 
given to the human and financial resource implications of mandatory vaccination policies or of 
soft mandates.
Integration with Occupational Health Policies
Policies on seasonal influenza vaccination of health workers should be an integral part of the 
national occupational safety and health policies and regulations and the occupational safety and 
health management systems in health facilities. 
Inclusion of seasonal influenza vaccination in occupational health policies will allow access to 
free vaccination for all the targeted health workers as per the Occupational Safety and Health 
Convention, 1981, Article 214 and the recommendations in the World Health Organization and 
International Labour Organization (WHO-ILO) Global Framework for National Occupational 
Health Programmes for Health Workers.5 Such a policy would also put the responsibility for 
health worker vaccination on employers, rather than on the health workers alone.
An integrated policy will enable greater coordination and collaboration between occupational 
health and immunization programmes and promote a joint approach to control of influenza in 
health facilities wherein vaccination is part of an infection control program that includes other 
infection measures to protect both health workers and patients. The occupational health pro-
gramme at the national level and the management system at the facility level also provide an 
enabling environment to create a culture for infection prevention within the workplace that will 
stimulate the implementation of the vaccination programmes.
Choice of vaccine product, schedule and timing of vaccination
Choice of product
WHO provides recommendations for the composition of influenza vaccines based on the infor-
mation provided by the WHO Global Influenza Surveillance and Response System.6 Based on 
these recommendations, manufacturers formulate Northern Hemisphere (NH) and Southern 
Hemisphere (SH) vaccines, which are generally accessible around September (NH) and April 
4 C155-Occupational Safety and Health Convention, 1981 (No. 155). https://www.ilo.org/dyn/normlex/en/f?p=NO
RMLEXPUB:12100:0::NO::p12100_instrument_id:312300 (Accessed 14 Mai 2019)
5 The sectoral dimension of the ILO’s work : Review of sectoral initiatives on HIV and AIDS Appendix II – WHO-
ILO WHO-ILO Global Framework for National Occupational Health Programmes for Health Workers.  
http://www.ilo.org/wcmsp5/groups/public/---ed_norm/---relconf/documents/meetingdocument/wcms_145837.pdf 
(Accessed 14 Mai 2019)
6 Influenza: vaccines. http://www.who.int/influenza/vaccines (Accessed 14 Mai 2019)
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(SH) of each year, respectively. A list of WHO prequalified vaccines with information on their 
characteristics is published on the WHO website.7 
Several different types of vaccines are available, including inactivated influenza vaccines (triva-
lent and quadrivalent composition), live attenuated influenza vaccines, adjuvanted vaccine, and 
recombinant vaccine. Being a health worker per se does not lead to a preference for any vaccine 
type (subject to country-specific marketing authorizations).8 Health workers who care for severely 
immunocompromised persons should preferably receive inactivated influenza vaccine (IIV). 
Price and supply availability of each product are additional considerations in informing the choice 
of product. 
Timing of vaccination
In countries where influenza infection is seasonal and seasonality patterns are defined, vaccina-
tion should ideally be scheduled before the start of the influenza season, allowing approximately 
14 days for induction of protective antibodies. Where delays in securing vaccine supply does not 
allow ideal timing to be met, vaccination should be initiated as soon as supplies are made available.
Furthermore, individual health workers should never be refused vaccination at any time during 
the influenza season if they are late in seeking vaccination.
In tropical and subtropical regions where several peaks may occur, vaccination should be timed 
before the main peak of transmission, using the most recent vaccine formulation available. Where 
no data on national influenza seasonality are available, countries could use data from epidemio-
logically similar countries. Toolbox 4 provides published information of influenza seasonality in 
the tropics and subtropics.
7 WHO Prequalified Vaccines. https://extranet.who.int/gavi/PQ_Web/ (Accessed 14 Mai 2019)
8 In some countries the quadrivalent vaccine is the product of choice. The WHO Strategic Advisory Group of Experts 
(SAGE) in immunization is currently reviewing the evidence and expected to make a recommendation in 2020.
Toolbox 4. Guidance on choice of product and timing  
of seasonal influenza 
Seasonal influenza policy use and effectiveness in the tropics and subtropics. Geneva: World Health 
Organization, 2016. 
 ƥ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910173/pdf/IRV-10-254.pdf  
(Accessed 14 Mai 2019)
 ➠ Influenza seasonality in the tropics and subtropics – when to vaccinate 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153003 
(Accessed 14 Mai 2019)
 ➠ WHO list of prequalified vaccines 
https://extranet.who.int/gavi/PQ_Web (Accessed 14 Mai 2019)
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Defining monitoring and disease impact measurement objectives
Ministries of Health would benefit from advice from the NITAG or other relevant advisory groups 
on the monitoring and impact measurement objectives so that they are taken into consideration 
during the planning and implementation of Monitoring and Evaluation (see chapter 4). 
NITAGs, with additional inputs from other relevant advisory groups and academia, should make 
recommendations on:
1. Monitoring and reporting of vaccination coverage, where possible by unit and type of 
care provided.
2. Measurement of vaccination impact, including:
 – Target groups (health workers and or patients) for impact measurement.
 – Outcomes to be monitored. e.g. influenza-like illness, laboratory-confirmed disease, 
severe disease, death, absenteeism, patient-related outcomes, etc.
 – urveillance strategies for measuring impact; if at sentinel sites, the number and dis-
tribution of sites.
 – Time periods for impact measurement, e.g. continued monitoring for an indefinite 
period or limited to a certain number of seasons.
These measurements would be useful to the NITAG in reviewing the impact of vaccination and 
making recommendations for optimizing the impact and the cost-effectiveness of vaccination. 
Impact measurement could also generate empiric data to allow for estimation of cost-effectiveness 
of vaccination. 
It should be noted that any such measurements should include data collection for multiple seasons 
since the intensity of transmission, the severity of infection and vaccine effectiveness varies from 
one season to another. For further details, see the section on Monitoring and Evaluation (chapter 4).
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Planning for successful vaccine introduction
Once a national vaccination policy has been established, it is necessary to convert the policy into 
operational plans that are fully costed, budgeted and include granular detail on the various pro-
gramme components related to the introduction of a new vaccine into the national programme.
The general concepts for addition of a new vaccine within the national immunization plans and 
the management of introduction are outlined in the WHO guide “Principles and considerations 
to adding a new vaccine to a national immunization programme: from decision to implementation 
and monitoring” (see Annex 3 for New Vaccine Introduction Plan Template). This section provides 
guidance on the additional elements specific to seasonal influenza vaccination of health workers. 
A vaccine introduction plan integrated into the annual plan for immunization along with the 
associated checklists enable programme planners to ensure that all the necessary preparations 
are in place for the timely and efficient introduction of a vaccine into the national programme. 
For easy access the links to the relevant Annexes of the WHO guide are provided in Toolbox 5.
In addition to the generic vaccine introduction checklist, the complementary checklist in Annex 2 
contains a list of issues specific to health worker immunization. The elements of this checklist 
Toolbox 5. Links to templates and checklists for a new vaccine  
introduction plan in “Principles and considerations to adding  
a new vaccine to a national immunization programme:  
from decision to implementation and monitoring” 
Generic template to guide the development of a national introduction plan
 Ʀ http://www.who.int/entity/immunization/programmes_systems/policies_strategies/vaccine_
intro_resources/nvi_guidelines/Annex3_NVI_Template_EN.doc (Accessed 14 Mai 2019) 
New vaccine introduction checklist, activity list and timeline of WHO new vaccine introduction guide 
provides advice on planning budgeting, activities, distribution of roles and responsibilities and 
timelines
 ƥ http://www.who.int/immunization/programmes_systems/policies_strategies/vaccine_intro_
resources/nvi_guidelines/Annex4_Instructions.pdf (Accessed 14 Mai 2019)
Corresponding checklist tool
 Ƨ http://www.who.int/entity/immunization/programmes_systems/policies_strategies/vaccine_
intro_resources/nvi_guidelines/Annex4_checklist_en.xls (Accessed 14 Mai 2019)
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should be added (as appropriate) to the more generic checklist of activities. A sample health facil-
ity checklist is also provided (Annex 3) to guide the preparations for vaccination at the health 
facility level.
The timelines for planning and introduction should be included in the checklists and/or as a 
separate Gantt chart to ensure that all the activities are completed in their appropriate order to 
allow timely implementation of vaccination activities. 
Cross-reference should be made to the relevant sections of the occupational health strategies and 
plans at both the national and health facility level (see previous chapter on integration of health 
worker influenza policies into occupational health policies and requirements) to facilitate a more 
cohesive approach to planning and implementation.
The WHO-ILO Global Framework for National Occupational Health Programme for Health 
Workers recommends that all countries identify the responsible person(s) for occupational health, 
both at the national and workplace levels. These focal points should be a part of the planning team 
at the national and health facility levels, respectively. Inclusion of the occupational health focal 
points would allow for an integrated approach to prevention of influenza in the work place where 
vaccination forms part of a larger package of interventions for influenza control, including other 
infection control measures to protect both health workers and patients. The labour – management 
committees for occupational safety and health in health facilities, where they exist, can help in 
engaging the management and the workers’ representatives in the implementation of the vaccina-
tion programme.
In addition to the national operational plans for the implementation of health worker vaccination, 
the national comprehensive multi-year plan (cMYP) for immunization should also be updated to 
include health worker immunization (Toolbox 6).
Costing and financing
As with the addition of any new vaccine to the national vaccination schedule, the vaccine and deliv-
ery costs should be estimated and included in the annual and multi-year immunization budgets. In 
addition to the costs of vaccines and supplies (syringes, needles, safety boxes etc.), costs for vaccine 
delivery (including human resources), annual communications/education and demand generation 
efforts at the national and health facility level, and monitoring and reporting would need to be 
included in the costs. Several tools and resources are available that could be used or adapted for 
costing, budgeting and securing finances for health workers vaccination (see Toolbox 7).
Since communications and other activities/interventions to enhance vaccination uptake will be 
required each year, these costs should be incorporated into the annual vaccine delivery costs and 
not considered only as a one-time activity. 
Toolbox 6. WHO-UNICEF guidelines for multi-year planning 
WHO-UNICEF guidelines for developing a comprehensive multi-year plan (cMYP)
 ➠ http://www.who.int/immunization/programmes_systems/financing/tools/cmyp
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In addition to costing and budgeting for annual health worker influenza vaccination, it may also 
be necessary to advocate with those responsible for allocating funds for health programmes to 
ensure that financing for vaccination is sustained. Toolbox 8 provides links to resources for advo-
cacy for sustainable financing.
Toolbox 7. Resources for costing and financing 
cMYP Costing and Financing Tool
 ➠ http://www.who.int/immunization/programmes_systems/financing/tools/cmyp 
(Accessed 14 Mai 2019)
Immunization Costing Action Network (ICAN) Immunization Delivery Cost Catalogue  
This interactive website provides information on vaccine delivery costs across different low and middle-
income countries through a variety of delivery strategies. 
 ➠ http://immunizationeconomics.org/ican-idcc (Accessed 14 Mai 2019)
WHO Flu tool for planning and costing maternal influenza vaccination (new name: SIICT tool) 
This tool is being expanded to include all influenza risk groups, including health workers.
 ➠ http://www.who.int/immunization/research/development/influenza_maternal_immunization/en/
index2.html (Accessed 14 Mai 2019)
Management Sciences for Health. Planning, costing and budgeting framework
 ➠ http://www.msh.org/resources/planning-costing-and-budgeting-framework (Accessed 14 Mai 2019)
Immunization financing: a resource guide for advocates, policy makers and program managers
 ➠ https://immunizationeconomics.org/imfin (Accessed 14 Mai 2019)
Toolbox 8. Resources for costing and financing 
Immunization advocacy library: Provides a number of tools and guides to convey the value  
of vaccination and the need to invest in vaccination
 ➠ http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publi-
cations/communication-and-advocacy/immunization-advocacy-library (Accessed 14 Mai 2019)
Two specific documents in this library are of relevance:
Workbook – advocacy for sustainable funding of immunization programmes
 ➠ http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publi-
cations/2015/workbook-advocacy-for-sustainable-funding-of-immunization-programmes 
(Accessed 14 Mai 2019)
How to prepare a financial profile of your immunization programme
 ➠ http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publi-
cations/2015/how-to-prepare-a-financial-profile-of-your-immunization-programme 
(Accessed 14 Mai 2019)
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Formative research to inform the planning process
To prepare for the launch of influenza vaccination, several countries have used formative research 
to better understand the factors affecting uptake of seasonal influenza vaccination in health work-
ers, including concerns, beliefs, information needs, cultural issues, and barriers to vaccination in 
order to develop a tailored plan to address them.
Formative research can include both quantitative and qualitative research and, in some situations, 
might include a desk review. Quantitative research may be used to identify the main predictors for 
low uptake of vaccination among health workers and the main drivers for compliance with vacci-
nation recommendations. Data may be collected through surveys and questionnaires administered 
to health workers. The sample should ideally include sufficient representation from the different 
categories of health workers since the perceptions and reasons for low uptake may vary between 
health worker groups, e.g. between doctors and nurses (40), as well as from a sample of primary, 
secondary and tertiary health care facilities and from different work areas within these facilities.
Qualitative research is insight research, based on understanding the audience’s point of view. It elu-
cidates new issues and provides a more in-depth understanding of the complex issues underlying 
the uptake of vaccination. Qualitative research methods commonly include focus group discus-
sions and individual in-depth interviews. The WHO European Regional Office has published a 
step-by-step field guide to qualitative research for new vaccine introduction (see Toolbox 9). To 
be useful, formative research must be properly planned and well executed, failing which there is a 
risk of drawing wrong conclusions. This requires time and resources. While it is useful to conduct 
such research to inform the planning process, if time and resources do not permit, the lack of 
such research should not delay seasonal influenza vaccine introduction, unless attitudes of health 
workers are expected to be an issue that may significantly and adversely impact vaccine uptake. 
When data from formative research are not available, data from such studies conducted in other 
countries may be used to inform the planning process. While the reasons for low uptake of vac-
cine are heterogenous, available evidence suggests that there is broad convergence on the major 
influencers of vaccine uptake among health workers, especially between countries within the 
same sub-region, which may be used in the initial planning process. The rapid appraisal of evi-
dence (10) summarizes the key findings from the published literature and this evidence could be 
used, as applicable and appropriate, in the absence of locally conducted research.
Data from the published literature may be complemented with information obtained through 
quantitative formative research using rapid surveys in a sample of health workers, ideally including 
different health worker categories. These surveys may be less resource intensive than qualitative 
formative research and could be completed without resulting in any delays to vaccine introduc-
tion. Annex 4 provides a sample questionnaire that may be used for such surveys.
Toolbox 9. Field Guide for qualitative formative research 
A field guide to qualitative research for new vaccine introduction 
 ƥ http://www.euro.who.int/__data/assets/pdf_file/0004/359878/EIW2018_FieldGuide_VaccineIntro.pdf 
(Accessed 14 Mai 2019)
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Further research may be conducted if vaccine uptake remains persistently low. The TIPflu tool is 
an important resource that may be used in such situations.
Communication and vaccine acceptance
Personal beliefs, cultural attitudes and perceptions about vaccination, in addition to official rec-
ommendations, often guide the actions of many of those responsible for delivery of vaccines and 
many recipients (51, 52). This also holds true at the level of health workers. Available evidence 
shows that there are often misperceptions about vaccination as well as a gap between knowledge 
and behaviours (53, 54). Thus, simply improving knowledge about the risks and benefits of vac-
cination among health workers has not proven to be sufficient to achieve optimal vaccination 
uptake. Achieving optimal vaccination coverage in health workers requires a multi-dimensional 
demand generation effort that is informed by a good understanding of the perception, motivators 
and barriers of vaccine acceptance among health workers, both as providers of vaccination and 
as recipients. 
Communications messages need to be tailored to address the needs of different health worker 
groups since available evidence suggests that perceptions about the need, risks and benefits of 
vaccination may vary between these groups (55). Current efforts mainly focus on preparing fact-
based approaches to preparing communication messages. However, these types of messages may 
need to be framed according to the intended audiences based on their level of education and 
understanding. Taking the preferred cognitive decision-making styles of the individual groups 
to be targeted into account may have greater impact (54). Framing such messages will require an 
understanding of vaccine psychology and cognitive decision-making and may require engagement 
of communication specialists. 
A traditional approach to communications regarding immunization was through the use of mass 
media. However, research has shown that mass media alone and a one-way communication to 
health workers may not be sufficient to optimize the uptake of vaccination. Individual and group 
communications, in this instance at the health facility level, will be required to build trust and 
motivate health workers to accept vaccination.
Including information on the relevance of vaccination of health workers (self-protection, responsi-
bilities towards patients, pandemic preparedness in the case of influenza) in pre-service curricula 
for medical schools, nursing schools and other training institutions targeting health professionals 
may help to better establish health worker vaccination as an organizing concept and create better 
informed health worker generations providing immunization.
Effective communications and demand generation activities are not a one-time event but need to 
be continuous and have the ability to quickly respond to the evolving perceptions about vaccina-
tion and quell rumours and mis-perceptions. Front line vaccination staff responsible for health 
worker influenza vaccination will need to be trained to be able to deal with vaccine hesitant health 
workers as well as vocal vaccine deniers9 who may negatively impact the uptake of vaccination (56).
9 Vocal vaccine deniers are at the extreme end of the subgroup of vaccine refusers and actively advocate against 
vaccination, using science denialism techniques to justify their beliefs (reference 32).
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A national vaccine communication working group that includes communications specialists will 
facilitate strong working relations with and collaboration among partners and allies, strengthen 
routine communication for immunization, and ensure well-coordinated and immediate response 
from all involved authorities to any safety event. Inclusion of members of the Occupational Safety 
and Health department and from professional societies in communicating with health work-
ers contributes to building trust and improving acceptance of vaccination. Representation from 
health workers, professional associations, and unions and from the different health worker cat-
egories targeted for vaccination would ensure that the viewpoints of each health worker category 
is taken into consideration in developing tailored communication materials.
A number of tools and guidance documents are available that can be used for developing an effec-
tive communications strategy and for framing the communications messages that are specifically 
tailored towards different health worker groups, including a template terms of reference for a vac-
cine communication working groups (Toolbox 10).
In addition to vaccination, the information and education and communication materials should 
also include information on other infection control measures to reduce transmission of influenza 
in the work place and steps to be taken should a health worker develop an influenza like illness.
Communications at the health facility level
Effective communications at the health facility level will benefit from a dedicated and well-trained 
team to deliver the communications strategy at the health facility level. Such a team should be 
established and trained well in advance of the planned introduction date and should include 
representation from the main health worker categories in the facility and an advocacy and 
communications specialist, if one is available. Ideally, communications for seasonal influenza 
vaccination should be part of a broader communications effort on control of influenza in health 
care settings.
Toolbox 10. Tools and guides for developing communications strategy  
 and messages 
Vaccination and trust library
 ➠ http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publi-
cations/vaccination-and-trust (Accessed 14 Mai 2019)
New vaccine introduction: checklist for planning communications and advocacy (2017)
 ➠ http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/
publications/2017/new-vaccine-introduction-checklist-for-planning-communication-and-advo-
cacy-2017 (Accessed 14 Mai 2019)
Template terms of reference for a vaccine communication working group
 ƥ http://www.euro.who.int/__data/assets/pdf_file/0005/337496/02_WHO_VaccineSafety_Sup-
portDoc_TOR_Proof7.pdf (Accessed 14 Mai 2019)
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Communication activities at the health facility level should begin sufficiently in advance of the 
planned date for the onset of vaccination, especially in countries introducing vaccination for the 
first time. Initial activities could include the display of information posters at all the relevant areas 
of the health facility. The manager of the health facility and the heads of all the relevant depart-
ments and clinical areas should be sent a formal communication along with sufficient copies of 
all information materials about vaccination to be displayed in each clinical area. Where possible, 
relevant information on influenza vaccination could also be sent to all health workers using e-mail 
and/or local social media networks.
In-person group briefings should complement the display and distribution of information materi-
als. Existing staff meetings could be leveraged to conduct these briefings. The number of in-person 
group briefings will depend on the size of the health facility and the number of targeted health 
workers. Larger health facilities (e.g. secondary and tertiary level health facilities) may need to 
conduct several briefing sessions to cover all the targeted health workers. Since communications 
messages may differ between different categories of health workers, consideration should be given 
to holding separate briefing sessions for each health worker category using information and mate-
rials relevant to them. To allow better communication and enough time for questions from health 
workers to be addressed, the size of each group should be designed to allow sufficient opportunity 
for interaction. Provision should be made to facilitate the participation of health workers working 
night shifts. The schedule for the briefings should be widely publicized within the health facility 
and reminders sent to promote high attendance.
In-person meetings should:
1. Explain why vaccination is important for themselves, their patients and families and for 
wider society – with a particular focus on severe outcomes associated with influenza;
2. Inform health workers about national policies;
3. Provide information on the safety of seasonal influenza vaccines;
4. Provide information on the timing and venue(s) for vaccination;
5. Explain potential consequences of non-vaccination;
6. Allow sufficient time for questions.
Consideration may be given to establishing a telephone hotline or web-based system to address 
questions from individual health workers. In addition to the display of posters and other com-
munications materials, the use of visible and removable stickers that can be displayed by health 
workers who have been vaccinated (e.g. on their ID badges) would serve as a visible reminder to 
their colleagues who have not been vaccinated. In addition, text messages, generic e-mails and 
social media platforms could be used to provide periodic reminders on vaccination.
Demand Generation at the Health Facility Level
In addition to communication strategies, behavioural science-based demand generation efforts 
can be implemented prior to the availability of vaccines in order to prime health workers for vac-
cination. These nudge-based interventions work by creating an environment that can influence 
behaviour in a predictable way but does not eliminate choice (57), and have proven effective in 
a variety of healthcare settings (58). These interventions can narrow the gap between intention 
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and actual behaviour, which is usually caused by individuals or health workers forgetting to get 
their vaccination or through barriers to convenient vaccination. Additionally, these interventions 
frequently can be implemented for relatively low cost (59). The figure below (Figure 3), adapted 
from the Nuffield Council on Bioethics, demonstrates the hierarchy of nudge-based interventions 
to improve vaccine uptake (60).
Nudges lower on the ladder are less aggressive but can still have a measurable impact. By providing 
health-facility vaccination rate feedback, a process used in the United States to improve uptake of 
childhood vaccination, progress in health facilities can be monitored, and provide motivation to 
health workers to improve their own vaccination practices (61).
Figure 3. Ladder of nudge interventions to increase vaccination rates. Source: Patel MS (ref. 32)
Guide choice through default options
Automatically set up appointment
for vaccination unless individual opts out
Enable choice
Increase options to obtain vaccination
such as at workplace or near home
Prompt implementation intentions
Ask individual to precommit to a time and location
to obtain vaccination
Frame information
Deliver social comparsion feedback on vaccination
rate among peers or healthier individuals
Provide information
Offer education on benefits of vaccination
to self ant others
Do nothing
Simply monitor vaccination rates
Reminders to individuals to vaccinate can serve as a nudge, notifying individuals when they are 
due for a vaccine and prompting them to come to the vaccination site to receive the vaccine. These 
can be paper-based or mobile phone text message-based and have proven effective (62). In the 
health facility, health worker reminders through an immunization data collection tool (whether 
paper- or electronic-based) can help improve the delivery of vaccines by health workers (59). 
A successful nudge-based strategy to reduce barriers to convenient vaccination and enable choice 
is standing orders. Standing orders are a policy put in place in a health facility that permits non-
physician health workers to administer vaccines without a prescription or explicit order from 
a physician and have proven one of the most effective strategies for improving vaccine uptake 
when applicable (63). All of these strategies can be combined with communication approaches to 
create demand in the community.
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Going beyond nudges
Nudges are a favoured method for influencing demand since they preserve choice and are not 
coercive. However, some experts have argued that when nudges fail to achieve optimal uptake of 
vaccination in health workers, and this failure results in harm to their patients, decision-makers 
should consider adopting more forceful policies (64). This is not to imply that when nudges fail 
one should immediately go to measures that eliminate choice. There are interventions that exist 
across a continuum leading up to restriction of choice. The use of “soft mandates” provide exam-
ples of actions across this continuum.
Case study: The «flulapalooza» campaign to increase uptake of seasonal  
influenza vaccination in health workers
Vanderbilt University Medical Center in Nashville, Tennessee, in the United States, employs over 24,000 
health workers. Since 2011, the cornerstone of its seasonal influenza vaccination campaign for health 
workers has been its mass influenza vaccination event, playfully named “flulapalooza”. This event vac-
cinates, on average, over 14,000 people in a single day. The closed point-of-dispensing (c-pod) design 
has been evaluated and refined over time to substantially increase administration efficiency and cover-
age rates. The event emphasizes a festive atmosphere while practicing critical pandemic vaccination 
skills among hospital occupational health and administrative leadership. 
This event achieves high coverage among categories of health workers who are present that day; how-
ever, due to the structure of nursing shifts and ward responsibilities at the institution, less than 30% of 
nursing staff are typically vaccinated at the event. Thus, the medical center combines flulapalooza with 
ward visits, mobile carts and other strategies to achieve its annual target of greater than 90% overall 
health worker vaccine coverage. Notably, although institutional policy gradually increased the difficulty 
of declination and eventually included disciplinary action in response for unexcused failure to vacci-
nate, it is notable that 92% coverage had been achieved in seasons before disciplinary policies were in 
place. Details of event design, workflow diagrams and practical, specific lessons learned are described 
in a publication available online. 
Source: Swift MD, Aliyu MH, Byrne DW, et al. Emergency preparedness in the workplace: the flulapalooza model for 
mass vaccination. American Journal of Public Health. 2017 sep;107(s2):s168–76.  
http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2017.303953
Annex 5 provides a table that lists the different communications and demand creation approaches, 
along with an indication of the effort required to implement the approach and the expected impact.
Vaccine procurement and supply chain management
Vaccine procurement
Accessing vaccines at optimal prices requires a good understanding of procurement mechanisms 
and systems, vaccine market dynamics, and the elements of vaccine pricing. Procurement starts 
with forecasting vaccine demand, followed by tendering, contracting and procurement processes. 
The tools and resources for vaccine procurement are listed in Toolbox 11. Procurement of sea-
sonal influenza vaccination may have some unique features and may require regulatory approvals 
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and advance purchase commitments with specific manufacturers shortly after the publication of 
the WHO recommendations on the seasonal vaccine formulation (in February for the northern 
and in September for the southern hemisphere) and well in advance of the influenza season.
Selection of the vaccine product and presentation
As with any other vaccine, the choice of product and presentation will depend on multiple fac-
tors including supply availability, price, ease of use, storage and transport requirements, vaccine 
wastage and missed opportunities for vaccination (e.g. postponing vaccination due to reluctance 
to open a 10-dose vial for only one or two individuals). The choice of vial size should be based on 
the number of doses to be delivered at each vaccination point and the number of sessions to be 
held at each point. The currently prequalified injectable seasonal influenza vaccines are available 
in single dose pre-filled syringes and in single and 10-dose vials. All the 10-dose vial presentations 
contain thiomersal as a preservative. However, it may be noted that not all the currently available 
prequalified products in 10-dose vials have market authorization for storage up to 28 days once 
opened, and not all products have a vaccine vial monitor (VVM). These aspects should be taken 
into consideration in selecting the product and presentation. The specifications of each product 
and presentation should be checked to confirm that they meet the requirements of the programme 
before a procurement order is placed. Information on WHO prequalified vaccines may be found 
on the WHO website (see Toolbox 11).
Forecasting vaccine demand is an important first step in vaccine procurement. Forecasting demand 
requires an estimate of the number of health workers who will be targeted for vaccination, the 
expected vaccination coverage, and an estimate of vaccine wastage. Ideally health workers in both 
public and private facilities would be targeted for vaccination. This process of estimating the size 
of the target population for health workers vaccination is likely to be more complex than for other 
vaccines targeting the general populations. The data to derive such estimates may also be more 
difficult to find, especially in low and middle-income countries. Toolbox 12 provides resources 
for estimating the size of the health work force and those that need to be targeted for vaccination.
Toolbox 11. Vaccine procurement tools 
Procurement mechanisms and systems
 ➠ http://www.who.int/immunization/programmes_systems/procurement/mechanisms_systems 
(Accessed 14 Mai 2019)
Vaccine product, price and procurement (V3P) web platform
 ➠ http://www.who.int/immunization/programmes_systems/procurement/v3p/platform 
(Accessed 14 Mai 2019) 
Vaccine market
 ➠ http://www.who.int/immunization/programmes_systems/procurement/market 
(Accessed 14 Mai 2019)
List of WHO prequalified seasonal influenza vaccines
 ➠ https://extranet.who.int/gavi/PQ_Web/ (Accessed 14 Mai 2019) 
31
2. Planning and managing vaccination of health workers
The global health workforce databases may not carry information on all the health workers cate-
gories that may be targeted for vaccination. For example, global databases may only have estimates 
of the numbers of doctors, nurses and midwives, but not other health worker categories. In such 
instances, rough estimates could be made based on ratios of those health workers for whom data 
are not available to those where data are available (e.g. ratio of physicians to laboratory workers). 
These ratios could be quickly obtained through a survey of a small representative sample (e.g. 
tertiary, secondary and primary) of health facilities. 
Since each health facility may be required to prepare beneficiary lists with the names of those 
targeted for vaccination, for tracking vaccination delivery, and for maintaining records of those 
vaccinated; the initial demand forecasts could be refined in subsequent years using data from 
these beneficiary lists and vaccination records.
Logistics and cold chain management
The handling of influenza vaccine is similar to most other vaccines in the national immunization 
programmes. It needs to be stored at 2–8 degrees Celsius. Since vaccination of health workers is 
expected to occur annually during a relatively short window period each year before the onset of 
the influenza season, a plan needs to be developed to ensure storage and transport of vaccine at 
the different levels involved in the supply chain during the window period chosen for vaccination. 
Tools and resources for vaccine forecasting, management and logistics are available on the WHO 
website (Toolbox 13). The cold chain volume requirement for each WHO prequalified product 
and presentation are available on the WHO website (please select the vaccine type and click on 
Toolbox 12. Resources for estimating target population size 
Global Health Observatory: Health Workforce
 ➠ http://www.who.int/gho/health_workforce
Global Health Workforce Statistics database. World Health Organization, Geneva
 ➠ http://www.who.int/hrh/statistics/hwfstats 
World Health Organization. Counting health workers: definitions, data, methods and global results. 
Geneva, 2007
 ƥ http://www.who.int/hrh/documents/counting_health_workers.pdf
Toolbox 13. Vaccine management and support resources 
The resources that can assist programme managers in supply chain and logistics support planning may 
be found at the WHO website at: 
 ƥ http://www.who.int/immunization/programmes_systems/supply_chain/resources/tools/en/
index4.html (Accessed 14 Mai 2019)
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the links for each individual product and presentation to obtain this information).10 At the health 
facility level, the focal point responsible for health worker vaccination should ensure that the vac-
cine doses required in the facility are included in the demand forecast and that sufficient storage 
space to accommodate the required vaccine doses is available prior to the anticipated date of vac-
cine arrival at the health facility.
Vaccination of health workers
Vaccination of health workers should ideally take place at the health facilities where the targeted 
health workers normally work to ensure convenient access to vaccination.
Case study: Using an immunization champion to enhance uptake  
of influenza vaccination in health workers in Oman
Oman has a universal free-of-charge, integrated health care system, which includes influenza 
vaccination of health workers. Oman is one of the few high-income countries in the WHO Eastern Medi-
terranean Region (EMR) that has achieved high influenza coverage among health workers (>80%). This 
was made possible by immunization champions. The minister of health in Oman is passionate about 
protecting the health of health workers and is at the forefront in taking the first influenza seasonal 
vaccine. As the patron of health worker community and an influential person in the country, this action 
has reinforced the importance of vaccination and continually helps promote influenza immunization 
programs. He has also been personally involved in the communication of vaccination messages to the 
health worker community.
Every health facility should prepare a health facility plan for implementing seasonal influenza 
vaccination of health workers well ahead of the influenza season. These plans should include 
measures to enable convenient access to vaccination for health workers in every shift. Different 
options may need to be determined at the health facility level to cover health workers during night 
shifts without resorting to 24-hour vaccination services, for example insuring the availability of 
vaccination just before or after a shift change.
A vaccination team should be established at the level of the health facility to coordinate the vac-
cination activities and optimize uptake under the overall supervision of the head of the facility. 
One person should be designated as the team leader. This could be either the occupational safety 
and health focal points, or the persons responsible for immunization activities in the health facil-
ity. In larger facilities the staff medical services may be tasked with this activity. Experience from 
some organizations and health facilities have shown that using “vaccination champions” from 
among the health workers may contribute to improving vaccination uptake among their peers. In 
some countries, a mobile team that goes to each clinical area in the health facility and provides 
vaccination has been successfully used.
10 WHO prequalified vaccines. https://extranet.who.int/gavi/PQ_Web/Browse.aspx?nav=3
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Training of the vaccination team
Training workshops for health facility vaccination focal points should be conducted to conduct 
training in developing a health facility plan and in implementing and monitoring vaccination 
activities. A standardized agenda, curriculum, resource documents, checklists and model forms 
for recording data, as required, should be created at the national level for use in these workshops 
so that training is uniform across all health facilities. To further ensure uniform training, the 
workshops could be conducted using teams of trainers who are themselves trained centrally and 
are assigned to each region/ subregion, using a cascade training approach. Short training videos 
may be used to achieve uniformity in content in the training. Web-based self-learning modules 
may be considered for those who were unable to attend the training sessions. 
The health facility vaccination team should have the capacity to classify health worker groups (see 
chapter 2 for sample risk categorization of health workers) and establish a list of health workers 
eligible for vaccination, with their designations, and areas of work. Where different vaccination 
policies apply to different risk categories, either separate lists should be created, or mechanisms 
established to easily identify and monitor the vaccination status of those in each category. The 
beneficiary lists should be developed sufficiently in advance of the start of vaccination activities 
and the relevant health workers informed on the need for vaccination.
In addition to health workers employed at the health facility, provision may be made to include 
health workers in smaller facilities within their catchment area, including private facilities, as per 
the national policy, should vaccination not be available at all facilities.
A mechanism for defaulter tracking and for sending reminders should be established at each 
health facility. For health workers who come into contact with high risk patients, (e.g. those in 
organ transplant, oncology, intensive care or perinatal units), the supervisors of those who have 
not been vaccinated before the start of the influenza season may need to be informed (local con-
fidentiality norms permitting) so that they can reinforce the written reminders or, in case of 
refusals, get active declination forms signed and institute infection control measures applicable 
to active refusals, e.g. reassignment of duties, wearing of masks etc. as per the established national 
of health facility policy.
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All countries should have a mechanism in place to monitor vaccine coverage as well as adverse 
events following immunization (AEFI) from the health facility to the national level and conduct 
at least one influenza vaccine post-introduction evaluation. However, measuring vaccine accep-
tance and vaccine effectiveness or impact will be necessary and feasible only in a setting where 
immunization targets are not reached and if funding is available.
Developing and updating information systems
Appropriate forms and data entry modules for recording and reporting vaccination data at the 
health facility level and processes for reporting the data should be established.
In developing tools and guidance for data collection, the need to include both public and private 
health systems should be considered. This may require mapping of existing health information 
systems and immunization data collection instruments as well as guidance on how these systems 
may be used to collect data on seasonal immunization of health workers.
Data collection systems may vary across health facilities depending on the size and available infra-
structure of the facility. However, each health facility must be provided with a standardized data 
reporting form to ensure that the data required for reporting to the national level are collected, 
irrespective of the data recording system used. This could include the name of the health worker, 
the health worker category, area of work, risk category, date of vaccination, the vaccine product 
and lot number. In developing the data reporting form, the advice provided by the NITAG on 
monitoring and impact assessment should be considered. 
All data collection systems, whether paper-based or electronic should have the capability for 
defaulter tracking and a system for generating and sending out reminders to defaulters. When 
using such reminder systems, protecting the confidentiality of data on the health and vaccination 
status of health workers will be critical and access to the data should be restricted to the facility 
vaccination coordinator.
Coverage monitoring
Several approaches for estimating health worker influenza vaccine coverage are available. The 
timing of such coverage measurement is important and should be coordinated with the timing 
of vaccination in the country. Given that influenza vaccine is usually administered in seasonal 
campaigns, frequent reporting (e.g. monthly) is recommended. Ideally, assessments should be 
done at the end of the season, when complete data are available and assessed and data cleaned for 
any inconsistencies.
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Health facility registries
Information on influenza vaccines administered to health workers should be included in existing 
records maintained as part of occupational health requirements and in vaccination registers as 
part of institutional monitoring mechanisms. Careful assessment of data discrepancies is required 
if reporting is done from multiple sources, and data protection issues should be judiciously consid-
ered. The minimum set of data will include the number of people receiving influenza vaccination 
during each annual season, the total number of targeted health workers, and the derived vac-
cination coverage (%). Often both numerator and denominator data can be obtained from the 
departments of occupational health at health facilities. For establishing more detailed denomina-
tors, nominal health worker records e.g. based on payrolls can be used as a first step. A beneficiary 
list of those targeted for influenza vaccination can be selected from these records by applying 
criteria related to the health worker’s risk of infection or of transmitting the infection to those 
for whom they care (see section on ‘Characterizing Target Groups for Vaccination’ and Table 1). 
Depending on the capacity of the reporting system and program, this could include tallying num-
bers by health worker category and risk profile to allow coverage estimates by subcategories, such 
as doctors, nurses, laboratory workers, or staff working in Intensive Care Units or general (e.g. 
medicine or paediatric) wards, etc.
If a vaccination registry does not exist, a crude estimate of coverage among health workers could 
be calculated by using the number of vaccine doses distributed to each facility minus the number 
of vaccine doses returned (unused) divided by the estimated number of health workers targeted 
for vaccination at the facility. 
A similar, rather imprecise method to assess coverage at the national level would be to use the 
regularly compiled data on health workers (as reported to WHO) to estimate the denominator 
(see Toolbox 12), as used for the vaccine demand forecast, and the overall number of vaccines 
administered as the numerator. This approach should only be used as a last resort where none of 
the other methods described are feasible.
Administrative data
If vaccines are provided free to health workers with government, national insurance system or 
employers bearing the costs, there may be regular, sometimes mandatory, reporting on the num-
ber of health workers who have received vaccinations at the institutional level. Such administrative 
data may be available from well-documented national vaccine programmes or from health insur-
ance records.
Surveys
Surveys to obtain data on vaccinations and other interventions should be performed every 3 to 
5 years and allow the identification of heterogeneity of coverage at the subnational level, important 
for the necessary adaptation of immunization practices. A representative sample of health workers 
can be selected though a stratified random sampling approach from national registries of health 
workers (e.g. professional organizations). If such registries are not available, a two-stage selection 
of health facilities and of health workers in these facilities can be done. If contact information 
is available, standardized interviews could be done face-to-face, by phone or via internet-based 
platforms. Without such information, online survey links could be provided to all health workers 
in the selected facilities with an invitation to access the survey platform using their mobile phones 
36
3. Monitoring and evaluation
or personal computers. It should be noted that when using this approach, self-reporting of vac-
cination may lead to overreporting.11 
In all of these approaches to estimate coverage it will be important to specify the categories of 
health workers, e.g. those with or without direct patient contact, the latter including students, 
trainees, volunteers, maintenance, information technology, food service staff etc., who have been 
included in the numerators and denominators. It is also important to specify if part-time per-
sonnel working during the influenza season were included in the coverage estimates. Where 
individuals for whom vaccination is not recommended are vaccinated, such as back office work-
ers or staff relatives, etc., care must be taken not to count these in estimating vaccination coverage. 
Refusal and completion rates of surveys will need to be monitored and adjustments for possible 
selection biases made in the analysis.
At times, influenza vaccination programs may merely set absolute number targets of health work-
ers to be vaccinated, based on the number of vaccines procured and available in a specific area or 
location. Such an approach, while followed in some countries, will not allow the proper estimation 
of coverage rates, including coverage by risk category, or comparisons over time, which will be 
important for interpreting any data on impact. It will also not enable identification of determi-
nants of vaccination or of refusers.
If available, data as well as methods used to estimate vaccination coverage for other regular health 
worker vaccinations should be accessed, e.g. for hepatitis B, measles, polio, pertussis or tetanus 
vaccines. It must be noted, however, that these vaccines are not provided on an annual basis and 
will often only be checked at entry to service. 
Toolbox 14 lists available tools for collecting and reporting immunization data and for estimating 
coverage.
11 Llupia A et al. Vaccination Behaviour Influences Self-Report of Influenza Vaccination Status: A Cross-Sectional Study 
among Health Care Workers. PLoS One 2012; 7(7):e39496. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394773/
Toolbox 14. Monitoring and evaluation tools and indicators 
Immunization in practice series, module 7: Monitoring and using your data. Describes how to collect 
and report data and how to monitor immunization performance
 ƥ http://www.who.int/immunization/monitoring_surveillance/resources/IIP_Module7.pdf 
(Accessed 14 Mai 2019)
Training for mid-level managers. Module 7: The EPI coverage survey (Document WHO/IVB/08.07). 
Geneva: World Health Organization; 2008. Provides a step-by-step walkthrough, including relevant 
guidance and tools, to plan and conduct a coverage survey of a newly introduced vaccine
 ƥ http://who.int/immunization/documents/MLM_module7.pdf (Accessed 14 Mai 2019)
WHO reference for estimating influenza vaccination coverage among target groups: Outlines differ-
ent methodologies that can be used to estimate national influenza vaccine coverage among high-risk 
groups targeted for vaccination 
 ƥ http://www.euro.who.int/__data/assets/pdf_file/0004/317344/Methods-assessing-influenza-
vaccination-coverage-target-groups.pdf (Accessed 14 Mai 2019)
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AEFI monitoring
As for any vaccine and target group, a functioning AEFI monitoring system is a basic requirement, 
since knowledge gaps and misperceptions about influenza vaccine safety among health workers 
are consistently identified in in the literature. 
The system utilized to monitor and investigate possible AEFIs when delivering influenza vaccine 
to health workers should ideally be integrated into existing AEFI surveillance systems in line 
with national regulations for the monitoring of vaccine safety. The NIP or other departments 
responsible for health worker influenza vaccination (e.g. occupational health) should work with 
the National Regulatory Authority to define roles and responsibilities in vaccine safety monitor-
ing. In countries using influenza vaccines for the first time, it could be conceivable to intensify 
AEFI surveillance during the first year of influenza vaccine introduction in order to provide quick 
feedback to stakeholders to help assure them of the safety of the vaccines in use.
A functioning AEFI monitoring system will detect and elucidate problems with vaccines, which 
could be due to the product itself, its quality, or errors in the administration of the vaccines. All 
vaccine recipients reported as having an event (including minor events) perceived to be related to 
the influenza vaccine should be reported to the AEFI surveillance system using standard report-
ing forms (see Toolbox 15). Given adequate reporting, the monitoring system should be able to 
evaluate the observed rate of reactions to influenza vaccine and compare this to the expected rates 
reported in the literature. For serious AEFIs, causality will normally be assessed by a group of 
experts. Importantly, and as for any vaccine, such a system needs to be able to identify a previously 
unknown or unexpected vaccine reaction that should be investigated in more depth. Care must be 
taken to ensure that coincidental events are not mistaken for vaccine reactions.
By establishing and enhancing AEFI systems, influenza vaccination can also be used to further 
improve the awareness of overall immunization safety in the health worker community.
Toolbox 15. AEFI-related information sources 
AEFI core variables, including data on case, vaccine, event and reporter
 ƥ http://www.who.int/vaccine_safety/initiative/tools/AEFI_core_variables_basics_EN_Dec2015.pdf 
(Accessed 14 Mai 2019)
Sample form for AEFI recording with detailed description of reporting elements
 ƥ http://www.who.int/vaccine_safety/initiative/tools/AEFI_reporting_form_EN_Jan2016.pdf 
(Accessed 14 Mai 2019)
Causality assessment of an AEFI: Provides the detailed methodology in a four-step process with 
access to a related software tool
 ➠ http://www.who.int/vaccine_safety/publications/gvs_aefi/ (Accessed 14 Mai 2019)
Vaccine safety training resources providing access to vaccine and pharmacovigilance training 
packages 
 ➠ http://www.who.int/vaccine_safety/initiative/tech_support/ (Accessed 14 Mai 2019)
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Monitoring and evaluation of vaccine acceptance
Key determinants of vaccine acceptance among health workers have been investigated and include 
the desire for self-protection and to protect family and patients. (see also section on communica-
tion and vaccine acceptance).
As part of an initial situation analysis of health worker influenza vaccination programmes, available 
information on policy, programmes and practices, the factors affecting acceptance and participa-
tion, and the influence of media and communications can be investigated through key informant 
interviews, or participatory workshops. Results of such an analysis could then be used to inform 
additional communication strategies addressing the identified concerns in a targeted manner. 
Other determinants can be explored through formative research. Both qualitative and quantita-
tive research methods can be used to evaluate changes in health workers’ knowledge, attitudes, 
practices and behaviours. Behavioural determinants that differentiate health workers who get 
vaccinated from those who do not should be assessed regularly. Understanding the reasons and 
reasoning behind health workers’ attitudes towards annual flu vaccination is useful for the devel-
opment of communications messages and products. Involving health workers in behavioural 
research related to their perceptions, beliefs, emotions and potential conflicts also provides an 
opportunity for the health worker community to be engaged in the approach, which can result in 
greater acceptance of the vaccination program.
Vaccine impact monitoring
After an influenza vaccine has been introduced in a population, additional studies may help in 
evaluating the impact of the immunization program. 
However, WHO does not recommend that vaccine impact or effectiveness studies be conducted by 
all countries with influenza vaccination programs, given their complexity and expense. A number 
of research networks worldwide conduct such studies and results can be expected to be applicable in 
other settings with similar influenza epidemiology and vaccination programs. The decision to carry 
out such studies should therefore be based on the need for country-specific estimates and on the 
local capacity to conduct such rigorous studies. If studies are not appropriately designed with ade-
quate sampling of different health worker categories, there is a risk of arriving at wrong conclusions.
Toolbox 16. Tools to assess vaccine acceptance among health workers 
TIP-FLU tool: Provides an approach and tools grounded in behavior change theories and health programme 
planning models to tailor seasonal influenza vaccination to the needs and attitudes of frontline HWs. 
 ➠ http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/publications/2015/
tailoring-immunization-programmes-for-seasonal-influenza-tip-flu.-a-guide-for-increasing-health-
care-workers-uptake-of-seasonal-influenza-vaccination-2015 (Accessed 14 Mai 2019)
TIP FLU case study Montenegro: Provides a practical example of the use of the TIP FLU tool.
 ƥ http://www.euro.who.int/__data/assets/pdf_file/0007/281860/Tailoring-Immunization-Pro-
grammes-Seasonal-Influenza-TIP-FLU.pdf (Accessed 14 Mai 2019)
39
3. Monitoring and evaluation
Before-after studies to demonstrate vaccine effectiveness are not advised for influenza, given that 
influenza vaccine effectiveness for preventing influenza symptoms in seasonal influenza epi-
demics display considerable heterogeneity.12 Studies to evaluate the impact of seasonal influenza 
vaccination in health workers can be even more complex, given the varying risk of infection and 
transmission to patients among different categories of health workers. 
In health workers, a general reduction in absenteeism or, if available, reduction in influenza-asso-
ciated absenteeism is often used as a surrogate indicator for the impact of an influenza vaccination 
programme. For this, health facility institutional monitoring would need to include disease rates 
in health workers, and a measure of sickness absence. Where possible, reporting days of absen-
teeism due to influenza-like illness (ILI) (or respiratory infections) should be recorded. This will 
include self-reported ILI with or without virological confirmation. Other non-specific outcomes 
include severe acute respiratory infection (SARI) and all-cause pneumonia requiring hospitaliza-
tion. It is important to note that all these clinical syndromes include various other respiratory 
pathogens against which influenza vaccine does not protect. If such assessments are done, they 
should ideally cover multiple seasons, since impact can vary substantially by season, else such 
studies will be quite difficult to interpret. 
Laboratory-confirmed outcomes (e.g. by RT-PCR and other molecular diagnostic tests) improve 
the specificity of influenza disease classification. Where possible, establishment of sentinel sites 
with such capacity could be considered for collecting samples from health workers for laboratory 
confirmation. In these sites, vaccine effectiveness could be assessed using a case-control design 
and comparing vaccine coverage in laboratory-confirmed versus test-negative cases, if vaccine 
coverage is sufficiently high. Any of these approaches require sophisticated laboratory capacity 
which is not available everywhere. 
The screening method is a study design which could also be used for health worker vaccine impact 
assessment: it uses individual-level data on vaccination history from cases and data on vaccina-
tion coverage in the health worker population from which the cases came. However, such a study 
requires accurate information on the vaccination status of the cases and of health worker vaccina-
tion coverage. 
Given the indication that annual influenza vaccination for health workers could reduce illness 
among the patients they care for, studies can be designed to evaluate the effect of health worker 
influenza vaccination on mortality, hospitalization, and influenza cases in patients of healthcare 
facilities. Several research approaches have been used in this context such as randomized trials or 
case-control approaches. Given the complexity of study designs, the conduct of such studies should 
be limited to research institutions that have the capacity and experience to conduct such studies. 
Economic assessments and cost-effectiveness evaluations may be considered once sufficient cost 
and impact data are available following influenza vaccine introduction. WHO provides a number 
of relevant resource documents, which are being further developed to specifically estimate vaccine 
introduction costs for health worker vaccination (Toolbox 17; see also Toolbox 2). Relevant data 
are not easily available everywhere and assessments can be difficult to perform, given the limited 
size of the group of health workers.
12 Evaluation of influenza vaccine effectiveness: A guide to the design and interpretation of observational studies, 
WHO 2017.
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Post-introduction evaluation
National Immunization Program Reviews routinely assess the use of specific vaccines about every 
5 years following a new vaccine introduction. Such NIP Reviews should include relevant items to 
identify possible programmatic areas related to the new vaccine use.
As needed in-between NIP Reviews, a specific influenza-related Post-Introduction Evaluation 
(I-PIE) tool may be performed after the first or second influenza immunization season.
The I-PIE package (Toolbox 18) includes a number of tools to support the planning and conduct 
of the evaluation, including standard questionnaires and data collection forms in paper or elec-
tronic format as well as reporting templates together with instructions on how to perform the 
I-PIE in a cost-efficient manner. These tools will need to be adapted to the specific country context 
and to the specifics of the vaccine formulation and presentations.
The I-PIE is performed at all levels of the health system and includes observation of practices at 
the points of vaccine administration, vaccine storage areas as well as data and record reviews. An 
I-PIE can thus provide a more immediate approach to assess the programmatic challenges and 
impact of influenza vaccine use, and to compare results across countries, enabling them to share 
and learn from each other’s experiences.
Toolbox 17. Influenza in health workers: Study methodologies 
Evaluation of flu vaccine effectiveness 2017: Provides detailed information for researchers who design 
observational influenza vaccine effectiveness studies and for public health scientists who interpret and 
apply the results of these studies. An annex will address the effectiveness of influenza vaccine in health 
workers
 ƥ http://apps.who.int/iris/bitstream/handle/10665/255203/9789241512121-eng.pdf 
(Accessed 14 Mai 2019)
Manual for estimating disease burden associated with seasonal influenza: Provides step-by-step 
approach to estimate influenza disease burden in the general population as well as those with specific 
conditions who are vulnerable to severe disease 
 ➠ http://www.who.int/influenza/resources/publications/manual_burden_of_disease/ 
(Accessed 14 Mai 2019)
Toolbox 18. Influenza post-introduction evaluation tools 
I-PIE tool with instructions and recording and reporting templates 
 ➠ https://www.who.int/immunization/research/development/influenza_maternal_immunization/en/
index4.html (Accessed 14 February 2019)
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Annex 1. Sample non-participation form
This form is to be used in cases of voluntary vaccination where health workers in the very high or high-risk 
categories who decline to participate in assessment, screening and vaccination in accordance with the national 
policy. Completion of the form is particularly important where failure to get vaccinated will result in reassign-
ment or require the use of protective measures to protect patients as specified in the national policy.
Non-participation in vaccination
1. I have read and understood the policy directive regarding seasonal influenza vaccination of health 
workers.
2. I decline to participate in vaccination against influenza.
3. I am aware of the potential risks to myself and/or others that my non-participation in vaccination 
may pose.
4. I am aware that my non-participation may result in my being reassigned to a non-high-risk area or 
in other requirements to protect others with whom I may come in contact, as per the national policy.
5. The reason for my non-participation is: 
Refusal to sign
In circumstances where the health worker refuses to sign this form, it should be noted on the form and 
the health worker should be notified of consequences, if any, as per the policy. 
Name of health worker:
Date of birth:
Health service/ facility:
Work area:
Signature:      Date:
OFFICE USE ONLY
I have discussed the potential risks that non-participation in vaccination may pose and the management 
of unvaccinated workers in accordance with the vaccination policy.
Name of vaccination team staff:
Designation:
Health facility /agency:
Signature:
Date: 
Annex 2. Complementary checklist for planning health worker immunization: 
national13 level
(To be adapted for local use)
To account for the specifics of seasonal influenza vaccination of health workers, the following ADDITIONAL 
elements may be added to the generic new vaccine introduction check list, see Annex 4 of the document “Princi-
ples and considerations for adding a vaccine to a national immunization programme” for the checklist structure.
Health worker seasonal influenza vaccination policy
1. National policy on seasonal influenza vaccination of health workers are published and dissemi-
nated to all relevant agencies and health facilities, including private health facilities and relevant 
professional societies.
2. The policy on seasonal influenza vaccination of health workers is reflected in the national  
occupational health policies.
3. The costs of seasonal influenza vaccination of health workers are included in either the immu-
nization or occupational health budget, as appropriate.
4. Surveillance system is in place for influenza activity, including defining start and end of the 
influenza season, to inform selection of the most appropriate vaccine formulation and timing 
of influenza vaccination.
Planning for successful vaccine introduction
5. A functional multidisciplinary coordination group is in place to discuss and promote access 
to a new target population of health workers, enabling the formation of partnerships which  
support and shape the national agenda.
6. The group includes focal points from the occupational health and immunization programs, 
professional organization representatives, and other relevant stakeholders.
7. A costed operational plan for health worker vaccination is developed and integrated into 
the national immunization plans and relevant occupational health plans.
Formative research (optional and to be included only if formative research is planned)
8. The need and scope of any formative research to be conducted in preparation for vaccine  
introduction is defined.
9. A research group to conduct formative research has been identified and terms of reference 
for the research has been developed.
Communications
10. National communications working group established for planning communications strategy and 
developing communications materials for health worker vaccination against seasonal influenza.
13 In some countries, especially large countries with decentralized system, elements of this checklist may also apply at relevant 
subnational levels, e.g. provincial level.
11. Tailored communications messages and materials developed along with an overall  
communications strategy.
12. Training for health facility communications teams is conducted.
Vaccine procurement and supply chain management
13. Target population size estimate developed and included in demand forecast.
14. Individual health facility demand estimated, and vaccine distribution plan developed.
15. Sufficient storage space for vaccines and supplies for seasonal vaccination at all levels  
established to accommodate vaccine during vaccination period.
Vaccine Delivery
16. Health facility vaccination delivery teams are established and trained.
17. System for management of vaccination refusals and implementation of infection control mea-
sures in place for prevention of nosocomial transmission, e.g. reassignment, wearing of masks, 
mandatory leave in case of ILI.
Monitoring and evaluation
18. Data recording and reporting tools developed and distributed including for coverage  
monitoring (updated administrative data and health worker surveys) and AEFI monitoring.
19. Post-introduction evaluation conducted within the first 2 seasons following vaccine 
introduction.
20. Possibilities reviewed for operational research to assess health worker vaccine acceptance.
Annex 3. Health facility checklist
(To be adapted for local use)
Communications Person Responsible Deadline Status
1. Health facilities communications working groups are established and trained
2. Health facility communications plan and schedule for group communications 
with health workers finalized
3. Adequate supplies of posters and information materials for health worker 
vaccination are available
4. Notification of vaccination sent out to targeted health workers and 
supervisors
5. Telephone hotline established to address individual queries from health 
workers
Storage capacity for vaccines and supplies
6. Adequate storage capacity for influenza vaccines and supplies during  
vaccination window period established
7. Adequate supplies of influenza vaccines and supplies for health worker  
vaccination available
8. Provision to deal with extra injection waste during period of vaccination
Vaccine Delivery
9. Vaccination delivery team established and trained and vaccination sites 
within health facility finalized
10. Categorization of health workers completed and beneficiary list  
for vaccination developed
11. System for management of vaccination refusals and implementation of infec-
tion control measures in place for prevention of nosocomial transmission, 
e.g. reassignment, wearing of masks, mandatory leave in case of ILI
Monitoring and evaluation
12. Data recording and reporting instruments available taking into account data 
protection issues
13. System for defaulter tracking and reminders established
14. Health facility registries updated to include influenza vaccination
15. AEFI monitoring and reporting systems updated to identify AEFI  
in health workers
16. Vaccine acceptance monitoring system to address uptake issues  
in health workers established (if uptake issues are observed)
Annex 4. Sample questionnaire for conducting a survey  
among health workers14
1 Name (optional)
2 Age (years)
3 Sex ¨ Male  ¨ Female
4 Job category14 ¨ Doctor
¨ Nurse/midwife
¨ Laboratory technician
¨ Other technical staff
¨ Other (specify)
5 Patient contact ¨ Direct ¨ Face-to-face but not direct ¨ None
6 Contact with high risk patients ¨ Yes  ¨ No
7 Work area (name of clinical area of work)
Statements Strongly agree Agree Neutral Disagree
Strongly 
disagree
1 Vaccination of health workers against diseases such  
as hepatitis B and influenza are important
2 If I was unvaccinated exposure to influenza would 
be a risk to my health
3 Exposure to influenza poses a risk to my patients’ health
4 Influenza vaccination poses a risk to my health
5 The benefits of vaccination are greater than the risks
6 My receiving vaccination will protect my patients
7 The best way to protect my patients is to combine seasonal 
influenza vaccination with other infection control measures
8 I am sufficiently informed about risks of influenza infection
9 I am sufficiently informed about the risks and benefits  
of influenza vaccination
14 Adapt for local use based on local health worker classification
The following factors that would influence my decision to accept vaccination
10 Recommendations from the national policy-making body 
(e.g. NITAG)
11 Endorsement of recommendation from the professional 
society to which I belong
12 If it is part of occupational health regulations/ requirements
13 Recommendation from my personal physician
14 Availability of vaccination at no cost to me
15 Easy access to vaccination at my place of work
16 Colleagues having been vaccinated
17 Previous experience with vaccination
18 Protecting my patients
19 Preventing/reducing absenteeism from work
20 Contributing to pandemic preparedness
Other factors that would affect my decision to accept influenza vaccination (list below)
21
22
23
Annex 5. Communications and demand generation:  
Stratification of approaches to developing the content
Approach Effort Impact
Health facilities communications working groups are established and trained
Developing the content for communication messages
Framing information by delivering social comparison feedback on vaccination rates 
among peers or healthier individuals Low Medium
Tailored communication based on cognitive styles and cultural behaviours Medium High
Communication methods
Distribution and display of Information, Education and Communication (IEC) materials Low Medium
Establish a specially trained communications team at health facility level to administer 
communications and demand generation approaches Medium High
Web-based (including FAQs and chat groups) and social media communications Medium Medium
Text message and e-mail reminders to health workers Low Medium
Small group in-person briefing meetings High Medium
Use immunization champions at national and health facility level Medium High
Demand generation approaches
Provision of free vaccines Medium High
Provide vaccination in the work area using mobile teams Medium High
Provide incentives or stimulate competition, e.g. awards to clinical areas  
with highest vaccination coverage Low Medium
Visible reminders and peer-pressure, e.g. badges or stickers worn by those  
who have been vaccinated Low Medium
Ask individual to commit to a time and location to obtain vaccination Low Medium
Increase options to obtain vaccination, either near home or at workplace Medium High
Guide choice through default options, e.g. automatically set up appointment for vaccina-
tion unless individual opts out Low High
Establish standing orders to facilitate vaccination Medium High
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